Results 21 to 30 of about 9,484 (203)

Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: A patient-use study

BMC Ophthalmology, 2008
Background The stability of ophthalmic preparations in multidose containers is influenced by the preservative as well as the stability of the active ingredient.
Umbelino Cristiano C, Kasahara Niro, Paolera Mauricio D, Walt John G   +3 more
doaj   +1 more source

Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs. [PDF]

, 2019
There is a limit beyond which increasing either the concentration of a prostaglandin analog (PGA) or its dosing frequency fails to produce increases in ocular hypotensive efficacy with topical dosing.
Alm, Blondeau, Brubaker, Celebi, Chen, Cymbor, Eveleth, Foroozan, Friberg, Funk, Funk, Katz, Krieglstein, Lee, Lee, Lee, Lewis, Lindén, Lovering, McDougal, Nagasubramanian, Ogundele, Phelps, Prum, Seal, Selbach, Selbach, Sherwood, Sit, Sit, Strohmaier, Tsai, Walløe, Watts, Wilke, Zamora, Zamora   +36 more
core   +2 more sources

Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease

Pharmaceuticals, 2022
To compare the efficacy, patient-reported satisfaction, and safety of preservative-free (PF)-tafluprost, PF-dorzolamide/timolol and preservative-containing (P)-latanoprost in Korean glaucoma patients with ocular surface disease (OSD).
Sang-Woo Park, Jiwoong Lee, Michael S. Kook   +2 more
doaj   +1 more source

A comparative study on the efficacy and cost-effectiveness of latanoprost and timolol in glaucoma

National Journal of Physiology, Pharmacy and Pharmacology, 2020
Background: Glaucoma is a chronic, progressive optic neuropathy which leads to optic nerve damage and loss of visual function. Elevated intraocular pressure (IOP) is the most important and only modifiable risk factor.
Iram Shaifali, Neetu Gupta, Shalini Chandra, Kanupriya Agarwal   +3 more
doaj   +1 more source

Matrix Metalloproteinases and Glaucoma Treatment. [PDF]

, 2020
Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade extracellular matrix (ECM) components such as collagen and have important roles in multiple biological processes, including development and tissue remodeling, both in ...
Dibas, Mohammed, Robinson, Michael R, Stamer, W Daniel, Weinreb, Robert N   +3 more
core  

Topical latanoprost causes posterior movement of lens in a patient with exfoliation syndrome and subluxated lens: a case report [PDF]

, 2007
Introduction To report the effect of topical latanoprost on the position of a subluxated lens. Case presentation After 0.005% latanoprost was administered topically to a patient with ocular hypertension due to a pseudoexfoliation syndrome and a ...
Takashi Kanamoto, Michiya Takamatsu, Yoshiaki Kiuchi, HK Mishima, HK Mishima, CB Toris, SY Yousufuzai, JD Lindsey, A Ocklind, AG Konstas, A Alm, Y Goh, JF Poyer, N Fujimoto, G Marchini, Y Nishida   +15 more
core   +1 more source

Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy

National Journal of Physiology, Pharmacy and Pharmacology, 2020
Background: Glaucoma is the second most common cause of blindness worldwide and also in India and its prevalence is increasing. Raised intraocular pressure (IOP) is most important and directly related to development of primary open-angle glaucoma (POAG).
Kalshetty Shivaleela, M Pradeep Kumar
doaj   +1 more source

Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male guinea pigs following repeated exposure

Folia Morphologica, 2022
BACKGROUND: Glaucoma is a group of eye diseases that can cause vision loss. Prostaglandin analogues (PGAs) are known to be first-line treatment for patients with glaucoma.
A. F. Ali, R. M. Salama, M. A. Soliman
doaj   +1 more source

Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study. [PDF]

, 2020
Background:Rising healthcare costs motivate continued cost-reduction efforts. To help lower costs associated with open-angle glaucoma (OAG), a prevalent, progressive disease with substantial direct and indirect costs, clinicians need to understand the ...
Cioffi, George A, Feldman, Robert M, Feldman, Robert M, Liebmann, Jeffrey M, Weinreb, Robert N   +4 more
core  

24-h Efficacy of Glaucoma Treatment Options [PDF]

, 2016
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss.
Banu, Bozkurt., Garcia-Feijoo, Julian, Katsanos, Andreas, Konstas, Anastasios, Miglior, Stefano, Pfeiffer, Norbert, Quaranta, Luciano, Rossetti, Luca, Shaarawy, Tarek   +8 more
core   +2 more sources